New LaunchJun 1, 2026, 08:33 AM
EUDA Health Launches Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
AI Summary
EUDA Health Holdings Limited announced the expansion of its Helixé product line with the launch of the Regenixé iPSC-derived Skin Stem Cell Secretome Mask. This new beauty product, developed by Chemokine Pte Ltd, utilizes iPSC-derived skin stem cell secretome technology for skin hydration, brightening, and recovery. EUDA, which holds exclusive global distributorship rights for Helixé products, intends to use its established networks in Malaysia and China to drive sales in the growing Asia-Pacific facial mask market, estimated at $7.95 billion in 2026 and projected to reach $9.08 billion by 2031.
Key Highlights
- EUDA Health launched the Regenixé iPSC-derived Skin Stem Cell Secretome Mask.
- The new beauty product was developed by Chemokine Pte Ltd.
- EUDA holds exclusive global distributorship rights for Helixé products, including the new mask.
- The global face mask market is estimated at $7.95 billion in 2026.
- The market is forecast to reach $9.08 billion by 2031.
- EUDA plans to leverage its distribution networks in Malaysia and China for sales.
Price Impact
More from EUDA